In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Curasept ADS 220 Drug Master File in Korea (Curasept ADS 220 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Curasept ADS 220. The MFDS reviews the Curasept ADS 220 KDMF as part of the drug registration process and uses the information provided in the Curasept ADS 220 KDMF to evaluate the safety and efficacy of the drug.
After submitting a Curasept ADS 220 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Curasept ADS 220 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Curasept ADS 220 suppliers with KDMF on PharmaCompass.